Jonathan French
Overview
Explore the profile of Jonathan French including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia R, Cheng S, Glassman F, Sharma A, De Miguel-Lillo B, Wiens M, et al.
CPT Pharmacometrics Syst Pharmacol
. 2025 Mar;
PMID: 40042097
Hereditary angioedema (HAE) is a rare genetic disease that manifests as recurrent, unpredictable, and potentially life-threatening attacks of angioedema. Garadacimab is a first-in-class, fully human, monoclonal antibody targeting activated factor...
2.
Eagle S, Preszler J, Brunner M, Manderino L, Zynda A, French J, et al.
J Pediatr Surg
. 2024 Oct;
60(2):162006.
PMID: 39461142
Objectives: To investigate whether there are empirically-detectable subgroups of concussion severity and recovery across three consecutive concussions, as well as to define risk factor and clinical assessment differences across subgroups....
3.
Goteti K, Garcia R, Gillespie W, French J, Klopp-Schulze L, Li Y, et al.
CPT Pharmacometrics Syst Pharmacol
. 2023 Dec;
13(2):281-295.
PMID: 38050332
Several investigational agents are under evaluation in systemic lupus erythematosus (SLE) clinical trials but quantitative frameworks to enable comparison of their efficacy to reference benchmark treatments are lacking. To benchmark...
4.
Johnston C, Waterhouse T, Wiens M, Mondick J, French J, Gillespie W
CPT Pharmacometrics Syst Pharmacol
. 2023 Nov;
13(2):192-207.
PMID: 38017712
Bayesian estimation is a powerful but underutilized tool for answering drug development questions. In this tutorial, the principles of Bayesian model development, assessment, and prior selection will be outlined. An...
5.
Grisic A, Venkatakrishnan K, French J, Khandelwal A
CPT Pharmacometrics Syst Pharmacol
. 2022 Dec;
12(2):144-147.
PMID: 36537836
Key elements of scientific writing-consistency and clarity-can be compromised in case of inaccurate use of methodological terms, especially in complex and multidisciplinary scientific fields. Such is the case in reports...
6.
Assiotis A, French J, Edwards G, McCann P, Chalk N, Amirfeyz R
Shoulder Elbow
. 2022 Dec;
14(6):677-681.
PMID: 36479012
Background: Distal biceps rupture presents with an increasing incidence and evidence suggests that although a surgical repair is not mandatory, it results in superior functional outcomes when compared to non-operative...
7.
Parsons T, French J, Oshima T, Figueroa F, Neri T, Klasan A, et al.
Antibiotics (Basel)
. 2022 Nov;
11(11).
PMID: 36421314
(1) Background: Prophylactic systemic antibiotics are acknowledged to be an important part of mitigating prosthetic joint infections. Controversy persists regarding optimal antibiotic regimes. We sought to evaluate current international antibiotics...
8.
Goteti K, French J, Garcia R, Li Y, Casset-Semanaz F, Aydemir A, et al.
CPT Pharmacometrics Syst Pharmacol
. 2022 Nov;
12(2):180-195.
PMID: 36350330
Systemic lupus erythematosus (SLE) is an autoimmune disease affecting multiple organ systems. Many investigational agents have failed or shown only modest effects when added to standard of care (SoC) therapy...
9.
Kay K, Goodwin J, Ehrlich H, Ou J, Freeman T, Wang K, et al.
Clin Pharmacol Ther
. 2022 Oct;
113(3):660-669.
PMID: 36260349
Artemisinin-based combination therapies (ACTs) are the primary treatment for malaria. It is essential to characterize the pharmacokinetics (PKs) and pharmacodynamics (PDs) of ACTs in vulnerable populations at risk of suboptimal...
10.
Khandelwal A, Grisic A, French J, Venkatakrishnan K
Clin Pharmacol Ther
. 2022 Mar;
112(5):941-945.
PMID: 35286713
No abstract available.